对维生素B12的基托桑基输送系统的审查:进展,挑战和未来前景
Radhika Joshi1, Shilpa Chandel2, Isha Roy3
1Department of Bioscience & Biotechnology, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India; Department of Pharmacy, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India.
International journal of biological macromolecules
|February 15, 2026
概括
奇托桑通过改善吸收和保护其免受降解来增强维生素B12的输送. 这种生物聚合物在食品和药品中提供了多样化的应用,但长期安全性需要进一步研究.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 营养科学 营养科学
背景情况:
- 酸盐是一种酸盐衍生物,是一种有着显著的维生素B12输送潜力的酸盐生物聚合物.
- 它解决了生理和配方障碍,提高了像维生素B12这样的爱水化合物的生物可用性.
研究的目的:
- 审查基托桑作为维生素B12输送的载体的特性和应用.
- 探索各种基于酸盐的输送系统及其输送途径.
- 识别当前的进展,挑战和翻译前景.
主要方法:
- 科学文献的回顾,关于酸盐介导的维生素B12输送.
- 分析基托桑的粘膜粘合特性和与上皮紧密结合的相互作用.
- 检查不同的奇托桑配方 (纳米颗粒,水凝,改性衍生物) 和注射途径.
主要成果:
- 素表现出粘膜粘附性,增强粘膜的存在,并使内在因子独立的吸收.
- 它保护维生素B12免受胃肠道的降解,保持生物活性.
- 像纳米颗粒和水凝这样的基托桑平台提高了生物可用性,可控释放和在各种路径上有针对性的输送.
结论:
- 基于酸盐的系统为食品和制药应用中的维生素B12输送提供了有希望的进步.
- 需要进一步的研究来应对与长期安全性,免疫性和药理动力学相关的挑战,特别是对于新的输送途径.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
227
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
227
Modified-Release Drug Delivery Systems: Bioavailability
17
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
17
Modified-Release Drug Delivery Systems: Overview
17
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
17
Site-Targeted Drug Delivery Systems: Polymeric Carriers
17
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
17
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
228
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
228
Oral Drug Delivery Systems: Introduction
22
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
22


